All In Biotech

Drug Trial Radar · NCT04871451

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia

Last checked: Nov 20, 2026Latest source record: Aug 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

51

Actual

Start

Jul 27, 2021

Primary completion

Jul 24, 2023

Study completion Jul 24, 2023

Sponsor

Lead sponsor
AEON Biopharma, Inc.Industry
Sponsor type
Industry
First posted
May 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Open-label Extension trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 42 sites in the United States from Phase 2 (ABP-19000) trial. Study subjects who had their initial dose of study drug in the Phase 2 trial, irrespective of treatment allocation, will be eligible to enroll in this OLE study.

Conditions

  • Cervical Dystonia

Interventions

  • ABP-450Drug

    ABP-450 (prabotulinumtoxinA) contains a 900kDA botulinum toxin type-A complex produced by the bacterium Clostridium botulinum.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-related Serious Adverse EventsTime frame: Up to 52 weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Neuroscience Research

    Phoenix, Arizona

  • Parkinson's and Movement Disorder Institute

    Fountain Valley, California

  • Neuro Pain Medical Center

    Fresno, California

  • Loma Linda University

    Loma Linda, California

  • New England Institute for Neurology and Headache

    Stamford, Connecticut

  • Infinity Clinical Research LLC

    Hollywood, Florida

  • Brainstorm Research

    Miami, Florida

  • University of South Florida

    Tampa, Florida

  • Neurology One

    Winter Park, Florida

  • Emory University

    Atlanta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • Michigan State University

    East Lansing, Michigan

  • Quest Research Institute - Hunt - PPDS

    Farmington Hills, Michigan

  • University of New Mexico

    Albuquerque, New Mexico

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • Cleveland Clinic Lou Ruvo Center for Brain Health

    Cleveland, Ohio

  • The Orthopedic Foundation

    New Albany, Ohio

  • Veracity Neuroscience LLC

    Memphis, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Baylor College of Medicine

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.